Surprising sign of Parkinson's disease that appears decades before onset of tremor
Early signs of Parkinson's disease may manifest as subtle vocal changes, such as a soft or monotonous voice, decades before ...
Morningstar26 天
Roche's Parkinson's Drug Candidate Misses Key Goal in Mid-Stage Study — Update
Roche said a Parkinson's disease experimental drug missed its primary goal in a mid-stage trial, the second setback this week for candidate treatments for the neurodegenerative condition.
MarketWatch26 天
Roche's Parkinson's Drug Candidate Misses Key Goal in Mid-Stage Study -- Update
Roche said a Parkinson's disease experimental drug missed its primary goal in a mid-stage trial, the second setback this week for candidate treatments for the neurodegenerative condition.
Reuters1 个月
AbbVie's Parkinson's disease drug improves patient mobility in late-stage study
Dec 9 (Reuters) - AbbVie's (ABBV.N), opens new tab experimental drug to treat early Parkinson's disease helped significantly ... in a separate study. The late-stage study tested the safety and ...
Benzinga.com26 天
Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On ...
Partner Roche Holdings AG RHHBY conducted the 586-subject study investigating prasinezumab in early-stage Parkinson’s disease patients who had been treated for a minimum of 18 months while on ...
Business Wire26 天
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible ...
PRTA), today announced results from the Phase IIb PADOVA study conducted by partner Roche investigating prasinezumab in 586 people with early-stage Parkinson’s disease, treated for a minimum of ...